Series B funding round for Effector Therapeutics raising $16M in February 2016
Series B funding round for Effector Therapeutics raising $16M in February 2016
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$140M
Top Valuation
-
Effector Therapeutics raised $16M in a Series B round.
The round was announced on 02/01/16.
The round was led by Maha Katabi, PhD, CFA.